M. Bektas Et Al. , "A severe case of bevacizumab-induced thrombotic microangiopathy," JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.25, no.7, pp.1754-1757, 2019
Bektas, M. Et Al. 2019. A severe case of bevacizumab-induced thrombotic microangiopathy. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.25, no.7 , 1754-1757.
Bektas, M., Samanci, N., Cokgezer, S., Keskin, D., & Demirelli, F. H., (2019). A severe case of bevacizumab-induced thrombotic microangiopathy. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.25, no.7, 1754-1757.
Bektas, Mert Et Al. "A severe case of bevacizumab-induced thrombotic microangiopathy," JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.25, no.7, 1754-1757, 2019
Bektas, Mert Et Al. "A severe case of bevacizumab-induced thrombotic microangiopathy." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.25, no.7, pp.1754-1757, 2019
Bektas, M. Et Al. (2019) . "A severe case of bevacizumab-induced thrombotic microangiopathy." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.25, no.7, pp.1754-1757.
@article{article, author={Mert Bektas Et Al. }, title={A severe case of bevacizumab-induced thrombotic microangiopathy}, journal={JOURNAL OF ONCOLOGY PHARMACY PRACTICE}, year=2019, pages={1754-1757} }